Undergoing bariatric surgery to combat obesity will stop women from developing womb cancer conjointly referred to as female internal reproductive organ or endometrial cancer claims a study. The findings, led by scientists from the University of Manchester, showed that women who had the gastric sleeve or bypass surgery for obesity found that malignant neoplasm tissue in their female womb reverted to normal tissue once they lost weight.
“For super obese women, fast access to weight loss surgery has edges on the far side up polygenic disorder and risk of heart disease. It can also reduce womb cancer risk,” said Emma Crosbie, the clinical senior lecturer from Manchester. “Losing weight through dieting is also doubtless to be effective, however, we all know that diet is incredibly laborious to try and weight loss is usually regained,” she said.
In the study, published in International Journal of Cancer, the team examined nearly a hundred women with an average BMI of over 50 — the thought of to be super obsessed — had biopsies taken from their wombs throughout gastric sleeve or bypass surgery Obese postmenopausal women produce estrogen from their fat stores. But as they no longer ovulate, the lack of progesterone allows the cells in the womb to grow, which increases the risk of cancer.
Inflammatory responses and internal secretion production are also changed in obese women and can cause cells in the womb to grow. “Because the reversal of malignant neoplasm changes in the womb was so fast, we expect the metabolic consequences of weight loss surgery was crucial,” same Crosbie.
However, the researchers stressed that the surgical option was not for everyone, because it was not an easy choice. “It changes your relationship with food forever, as you’ll be eating smaller meals more frequently, and it is important to remember that surgery can be a hazardous procedure,” said Crosbie. “But for those that choose it, gastric sleeve or bypass surgery can now be seen as a preventative measure for womb cancer.”